Product NDC: | 0169-3696 |
Proprietary Name: | NovoLog Mix 70/30 |
Non Proprietary Name: | insulin aspart |
Active Ingredient(s): | 100 [iU]/mL & nbsp; insulin aspart |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0169-3696 |
Labeler Name: | Novo Nordisk |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021172 |
Marketing Category: | NDA |
Start Marketing Date: | 20020911 |
Package NDC: | 0169-3696-19 |
Package Description: | 5 SYRINGE, PLASTIC in 1 CARTON (0169-3696-19) > 3 mL in 1 SYRINGE, PLASTIC |
NDC Code | 0169-3696-19 |
Proprietary Name | NovoLog Mix 70/30 |
Package Description | 5 SYRINGE, PLASTIC in 1 CARTON (0169-3696-19) > 3 mL in 1 SYRINGE, PLASTIC |
Product NDC | 0169-3696 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | insulin aspart |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20020911 |
Marketing Category Name | NDA |
Labeler Name | Novo Nordisk |
Substance Name | INSULIN ASPART |
Strength Number | 100 |
Strength Unit | [iU]/mL |
Pharmaceutical Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |